Cancer care during the COVID-19 crisis has been “de-prioritised, delayed,” and in some places, discontinued, especially in the early days of the pandemic. Cancer patients “are facing disruption for all but the most urgent procedures,” a May article in The Lancet said. At Varian, we look for new ways to increase access to quality care for cancer patients. We offer cancer treatment technology and services around the world. We innovate tools to facilitate collaboration and knowledge sharing, and put artificial intelligence, machine learning and automation to work in the clinic. While these technologies and services were designed to improve access to care, they have proven to be very useful during this pandemic. Let me offer a few examples.